YALA Yalla reports Q4 2025 EPS of 02 slips 015 as investors seek full revenue breakdowns Is SelectIncome DNP stock outperforming similar companies Amgen Inc AMGN Sustained Biotech Sector Outperformance Backed by MoatLike Competitive Advantages